Former law minister Zaid Ibrahim demands govt transparency on vaccine agreements

The former law minister Datuk Zaid Ibrahim is calling the government to be transparent on the vaccine procurement, while adding that the transparency would aid in reducing the suspicion that the supply is being suppressed in order to create monopoly.

A media outlet reported that Zaid said that as the nation has only vaccinated about 4 per cent of its entire population, Malaysia has been in a struggle against the Covid-19 pandemic.

Related Posts

He added that the government’s lack of transparency to its people over the vaccine agreements is making the public suspicious of the supplies being throttled to create monopoly which keeps the prices of the vaccine unusually high.

That being said, Zaid called for the government to disclose the details of the vaccine procurements with the manufacturers.

He also questioned the conditions provided by the federal government during its announcement that both the state governments and private hospitals could procure the vaccines on June 3, he added that it can be done even without the approval from the National Pharmaceutical Regulatory Agency (NPRA).

Zaid said that mindless bureaucracy is unnecessary in this situation since the potential buyers would be the states themselves as well as the duly-licensed hospitals.

He added that The World Health Organization (WHO) and world-leading regulatory bodies such as the Federal Drug Agency (FDA) and the European Medicines Agency (EMA) have already given their approvals under emergency authorization to use several vaccines, including those by Moderna, Sinopharm, and Johnson & Johnson.

He questioned the need to still involve the NPRA in the approval process when WHO has already approved them under emergency circumstances.

Zaid said that this condition given from the government to ensure that the federal government will retain priority for vaccines which are being used in the National Covid-19 Immunisation Programme (NIP) at the moment could give rise to uneasiness among the people given the unclear nature of the vaccine agreements.

He questioned if questioned if state governments and private companies can directly negotiate with the vaccine manufacturers or if it is still necessary to go through Pharmaniaga or another intermediary.

He also asked the reason behind why does the government limits the vaccine options to only three under NIP, adding that incidents of red tape could bring the prices up the vaccine prices which is being procured by states and the private sector.  “We need to see a comprehensive plan in place, not a patchwork of confused thinking,” he concluded.

Katherine S

1/4 German, 3/4 Malaysian. I write, follow and monitor closely political news happening in Malaysia, and other happening news in the ASEAN region. Newswriter for the best ASEAN news website - The Asian Affairs.

Recent Posts

V Surprises ARMY with Two Holiday Releases: A Festive Collab with Park Hyo-shin and “White Christmas” Cover

For K-pop fans, the Christmas season this year has become even more magical as several of their preferred stars reveal…

November 22, 2024

Celine Names TWS as Global Ambassadors Following Suzy Bae Announcement

After Suzy Bae's nomination as Celine's worldwide ambassador, the venerable French luxury fashion company has taken another bold step choosing…

November 22, 2024

Reddit Faces Widespread Outage, Users Turn to Workarounds Amid ‘Server Error’ Messages

Thousands of users of the well-known social network Reddit were left without access after a major outage of the website.…

November 22, 2024

Anne Hathaway Casted as ‘Verity’ in Colleen Hoover’s Book Adaptation

Anne Hathaway is slated to play the much expected film version of Colleen Hoover's best-selling book Verity in front of…

November 21, 2024

Gucci Set to Revolutionize Fashion Presentations with Unified Shows in 2025 under Sabato De Sarno’s Vision

Gucci is ready to change its presentation approach for 2025 in a radical action aimed to revolutionize the fashion industry.…

November 21, 2024

South Korea’s “Korea Discount”: Addressing the Governance Gap to Boost Market Value

As world investors wait for significant changes that might solve long-standing problems of governance and responsibility in South Korea's companies,…

November 21, 2024

This website uses cookies.

Read More